Low drug resistance to both platinum and taxane chemotherapy on an in vitro drug resistance assay predicts improved survival in patients with advanced epithelial ovarian, fallopian and peritoneal cancer
Koji Matsuo, Virginia K. Bond, Michele L. Eno, Dwight D. Im, Neil B. RosensheinVolume:
125
Year:
2009
Language:
english
Pages:
7
DOI:
10.1002/ijc.24654
File:
PDF, 216 KB
english, 2009